BioCentury | Oct 13, 2014
Company News

Genetic Technologies sales and marketing update

Genetic Technologies' Phenogen Sciences Inc. subsidiary launched BREVAGenplus in the U.S. to assess a women's risk of developing sporadic or non-hereditary breast cancer. According to Genetic Technologies, the test is designed for Caucasian, Hispanic and...
BioCentury | Jun 27, 2011
Company News

Genetic Technologies sales and marketing update

Genetic Technologies' Phenogen Sciences Inc. subsidiary launched the BREVAGen genetic test in the U.S. to determine a patient's lifetime and five-year risk for developing non-familial breast cancer. The breast cancer stratification test combines a DNA-based...
Items per page:
1 - 2 of 2
BioCentury | Oct 13, 2014
Company News

Genetic Technologies sales and marketing update

Genetic Technologies' Phenogen Sciences Inc. subsidiary launched BREVAGenplus in the U.S. to assess a women's risk of developing sporadic or non-hereditary breast cancer. According to Genetic Technologies, the test is designed for Caucasian, Hispanic and...
BioCentury | Jun 27, 2011
Company News

Genetic Technologies sales and marketing update

Genetic Technologies' Phenogen Sciences Inc. subsidiary launched the BREVAGen genetic test in the U.S. to determine a patient's lifetime and five-year risk for developing non-familial breast cancer. The breast cancer stratification test combines a DNA-based...
Items per page:
1 - 2 of 2